Occurrence of depression and anxiety prior to Parkinson's disease.
about
Neuroplasticity and the next wave of antidepressant strategiesProdromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedModulatory effects of α7 nAChRs on the immune system and its relevance for CNS disordersMelatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsThe association between ambient exposure to organophosphates and Parkinson's disease riskNon-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serumDepression and subsequent risk of Parkinson disease: A nationwide cohort studyDiagnostic accuracy and agreement across three depression assessment measures for Parkinson's diseaseSerum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.Neurobiology of depression and anxiety in Parkinson's diseaseDaytime napping, nighttime sleeping, and Parkinson disease.The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Impact of anxiety on quality of life in Parkinson's disease.Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's DiseaseMotor symptoms at onset of Parkinson disease and risk for cognitive impairment and depressionThe Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's DiseaseCommon Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for Parkinson's Disease: An Observational and Case-Control Study.Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene-Pesticide Interactions in a Case-Control Study of Parkinson's Disease, California (USA).Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort studyFunctional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposureEmergence of nonmotor symptoms as the focus of research and treatment of Parkinson's disease: introduction to the special section on nonmotor dysfunctions in Parkinson's disease.Household organophosphorus pesticide use and Parkinson's disease.Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease.Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.Neuropsychiatric symptoms in untreated Parkinson's disease.Personality traits in patients with Parkinson's disease: assessment and clinical implications.The clinical spectrum of anxiety in Parkinson's disease.Management of anxiety and motor symptoms in Parkinson's disease.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.Emotional manifestations of PD: Neurobiological basis.Psychosocial risk factors for hospitalisation and death from chronic obstructive pulmonary disease: a prospective cohort study.Depression in Parkinson's Disease: The Contribution from Animal Studies.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Premotor Diagnosis of Parkinson's Disease.Disease-specific anxiety symptomatology in Parkinson's disease.
P2860
Q21129480-D4A477B8-5BAC-4102-A285-2643A32E0AAFQ26738357-F063919C-99F1-4570-B93A-3A00E3AA47DCQ26765419-63846C5E-38D2-4019-8F73-415731A0F781Q28075345-D2B5876E-03B3-461D-891F-8899E342656CQ28389413-69956D28-8DBD-487F-8AEB-616065B42D4EQ34452085-99D0A2CA-EE30-4BE9-BCE2-8BADCACD69B0Q34477187-86FCFE8F-F7A3-4978-B52E-CEA38222B3D9Q34493954-B89C9AC0-07F5-43A7-B94A-944CE2CBBFECQ35027763-06782C31-A8A6-40F9-8D2B-9B52516A3C88Q35028706-F9EF0D4B-2169-4DA9-A87B-FD04E3BB16E2Q35062700-42C18AFC-A3A1-4F25-AC9C-BF63BF04802BQ35098556-BD378B9C-DDAB-466F-B2FF-7BB9ADA2B7B5Q35158376-F8C60C58-0D3C-4CDC-84AE-C882A089F93CQ35609023-06EF3ACB-08EB-4FA8-BFE4-A07B203915A8Q36149712-B3C4A2E7-5411-45DE-A2C7-BD35F0C47EF5Q36336894-14DBB338-51F9-4A39-8005-B09F9302055BQ36494212-F1E5722D-2333-4EE0-9755-AD7767F7413AQ36858244-912A5795-FC46-4A48-A0DE-CC480BCFE334Q36874319-B2437F4C-EB4D-4687-993A-F6BBAFE923C2Q36876199-8AEF519C-286E-4E0B-A7E0-21F0B12D9523Q36948705-8FECF9D6-D690-44CC-A817-E8170A236B44Q37136542-4637B4FD-E53E-4544-8B8A-12D5B192FE58Q37253501-4D387365-1B2D-45A8-98D6-53C073DC6FD1Q37320854-EA49210B-6FAA-4CB3-B76D-74AF423E89DEQ37565100-D85B2B27-9053-45A3-BBF8-FF2C8B40D394Q37671088-F71C7978-05AB-4C9A-A90F-C5A8A2C3594FQ37714081-159B80E0-DE44-4458-8B29-2527945B02E9Q37956163-2DCE9D07-E637-40E7-86E0-7703438E6F8DQ38231914-1AAEC968-2BB9-4EE3-972B-A7455608EC1BQ38233285-9E645A3A-0CCF-44F0-88E8-E8166EE1B4A7Q38650395-C80DCAA2-2B4E-4538-B086-BB72BB9F2BADQ38797335-997C5542-F32E-4FA2-8F6D-33F115D1F196Q39170790-F87A798E-027F-4777-A41A-BC67C656D814Q44130207-A962EBB4-ABBE-44B0-8277-1586B0F6895BQ47137783-77A94A36-2353-40C7-BF2E-FE7DF4E00DF4Q47701138-5D7BBAD9-74AA-43FB-90D2-4FC0F32A6A3AQ48869669-6635C4D7-F4C6-467E-8B84-736355820D9C
P2860
Occurrence of depression and anxiety prior to Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Occurrence of depression and anxiety prior to Parkinson's disease.
@ast
Occurrence of depression and anxiety prior to Parkinson's disease.
@en
Occurrence of depression and anxiety prior to Parkinson's disease.
@nl
type
label
Occurrence of depression and anxiety prior to Parkinson's disease.
@ast
Occurrence of depression and anxiety prior to Parkinson's disease.
@en
Occurrence of depression and anxiety prior to Parkinson's disease.
@nl
prefLabel
Occurrence of depression and anxiety prior to Parkinson's disease.
@ast
Occurrence of depression and anxiety prior to Parkinson's disease.
@en
Occurrence of depression and anxiety prior to Parkinson's disease.
@nl
P2093
P2860
P1476
Occurrence of depression and anxiety prior to Parkinson's disease
@en
P2093
P2860
P304
P356
10.1016/J.PARKRELDIS.2010.06.014
P577
2010-08-01T00:00:00Z